Over 12 weeks, LVEF further deteriorated significantly by ∼10% in controls (29.4 ± 3.9%) and only by half (∼5%) in HVP-treated animals (31.9 ± 3.0%), though differences between the groups did not reach statistical significance (Fig. 8c ).
← all excerpts
Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors.
1
—
—